Zhi Hong is the founder of Brii Biosciences. Brii Biosciences has raised $260M in total funding. Latest round: Series A. Based in Chapel Hill, United States.
Zhi Hong is a Co-Founder and CEO of Brii Biosciences, a biotechnology company focused on bringing innovative medicines to Chinese patients. He launched Brii with $260 million in committed capital in 2018, having previously worked at GlaxoSmithKline (GSK).
Full founder directory · Investor directory · Company funding database · Fundraising library